Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate

被引:0
|
作者
Xi WANG
Fan WANG
机构
[1] DepartmentofGeriatricCardiology,ChinesePLAGeneralHospital
关键词
D O I
暂无
中图分类号
R54 [心脏、血管(循环系)疾病];
学科分类号
摘要
Epidemiological studies and animal experiments have consistently demonstrated cardiovascular protection by high-density lipoprotein(HDL). Findings from a growing number of studies further indicate that sphingosine-1-phosphate(SIP) mediates many of the beneficial effects of HDL on the cardiovascular system, including vasodilatation, angiogenesis, maintenance of endothelial barrier function, and protection against atherosclerosis and ischemia/reperfusion injury. In this review, we summarize the most recent literature investigating the effects of HDL-S1P on cardiovascular health and highlight potential opportunities for clinical translation of these findings.
引用
收藏
页码:696 / 702
页数:7
相关论文
共 50 条
  • [21] High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
    Brinck, Jonas W.
    Thomas, Aurelien
    Brulhart-Meynet, Marie-Claude
    Lauer, Estelle
    Frej, Cecilia
    Dahlback, Bjorn
    Stenvinkel, Peter
    James, Richard W.
    Frias, Miguel A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (02)
  • [22] COMPARISION OF SERUM HIGH DENSITY LIPOPROTEIN AND SPHINGOSINE-1-PHOSPHATE LEVELS BETWEEN HYPERTENSIVE AND NORMOTENSIVE PREGNANCIES
    Dilmen, Erkan
    Gunyeli, Ilker
    Oral, Baha
    Erdemoglu, Evrim
    Guney, Mehmet
    Bayhan, Gokhan
    Mungan, Tamer
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 8 (03) : 164 - 168
  • [23] Sphingosine-1-phosphate and control of vascular tone
    Dantas, APV
    Igarashi, J
    Michel, T
    CIRCULATION, 2002, 106 (19) : 273 - 273
  • [24] Sphingosine-1-phosphate and modulation of vascular tone
    Igarashi, Junsuke
    Michel, Thomas
    CARDIOVASCULAR RESEARCH, 2009, 82 (02) : 212 - 220
  • [25] Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content Correction by Sphingosine-1-Phosphate-Loading
    Sattler, Katherine
    Graeler, Markus
    Keul, Petra
    Weske, Sarah
    Reimann, Christina-Maria
    Jindrova, Helena
    Kleinbongard, Petra
    Sabbadini, Roger
    Broecker-Preuss, Martina
    Erbel, Raimund
    Heusch, Gerd
    Levkau, Bodo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (13) : 1470 - 1485
  • [26] High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component
    Tamama, K
    Okajima, F
    Wells, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (02) : 271 - 272
  • [27] High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component
    Tamama, K
    Tomura, H
    Sato, K
    Malchinkhuu, E
    Damirin, A
    Kimura, T
    Kuwabara, A
    Murakami, M
    Okajima, F
    ATHEROSCLEROSIS, 2005, 178 (01) : 19 - 23
  • [28] High-density lipoprotein-associated paraoxonase 1: a possible prognostic biomarker for heart failure?
    Rom, Oren
    Aviram, Michael
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (06) : 756 - 759
  • [29] REGULATION OF THE SELECTIVE UPTAKE OF HIGH-DENSITY LIPOPROTEIN-ASSOCIATED CHOLESTERYL ESTERS
    RINNINGER, F
    PITTMAN, RC
    JOURNAL OF LIPID RESEARCH, 1987, 28 (11) : 1313 - 1325
  • [30] High-Density Lipoprotein Signaling via Sphingosine-1-Phosphate Receptors Safeguards Spontaneously Hypertensive Rats against Myocardial Ischemia/Reperfusion Injury
    Al-Jarallah, Aishah
    Babiker, Fawzi A.
    PHARMACEUTICS, 2024, 16 (04)